Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 9, 2009, Pages 1285-1288

  Liang, Feng ^a   Puche, Nathalie ^a   Soubrane, Gisèle ^a   Souied, Eric H ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Bruch's membrane rupture; Choroidal neovascularization; Intravitreal ranibizumab; Lucentis

Indexed keywords

RANIBIZUMAB;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; BLURRED VISION; BRUCH MEMBRANE; CASE REPORT; CORNEA ULCER; EYE EXAMINATION; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; MEMBRANE RUPTURE; OFF LABEL DRUG USE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; BRUCH MEMBRANE; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; EYE INJURIES; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INJECTIONS; MALE; RUPTURE; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 68549125163     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1098-2     Document Type: Article

References (8)

1. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ (2007) Pharmacokinetics of intravitreal ranibizumab(Lucentis). Ophthalmology 114:2179-2182, doi: 10.1016/j.ophtha.2007.09.012
2. Deissler H, Deissler H, Lang S, Lang GE (2008) VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab(Lucentis) in microvascular retinal endothelial cells. Br J Ophthalmol 92:839-843, doi: 10.1136/bjo.2007.135640
3. Yu HG, Liu X, Kiss S, Connolly E, Gragoudas ES, Michaud NA, Bulgakou OV, Adamian M, Deangelis, Miller JW, Li T, Kim IK (2008) Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest Ophthalmol Vis Sci 49:2599-2605, doi: 10.1167/ iovs.07-1508
4. Silva RM, Ruiz-Moreno JM, Nascimento J, Carneiro A, Rosa P, Barbosa A, Carvalheira F, Abreu JR, Cunha-Vaz JG (2008) Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization. Retina 28:1117-1123, doi: 10.1097/ IAE.0b013e31817eda41
5. Benevento JD, Jager RD, Noble AG, Latkany P, Mieler WF, Sautter M, Meyers S, Mets M, Grassi MA, Rabiah P, Boyer K, Swisher C, McLeod R (2008) Toxoplasmosis Study Group. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol 126:1152-1156, doi: 10.1001/archopht.126.8.1152
6. Narayanan R, Shah VA (2008) Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma. Eur J Ophthalmol 18:466-468
7. Pieramici DJ, Rabena M, Castellarin AA, Nasir M, See R, Norton T, Sanchez A, Risard S, Avery RL (2008) Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. Ophthalmology 115:e47-e54, doi: 10.1016/j.ophtha.2008.06.021
8. Chanana B, Azad RV, Kumar N. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic choroidal rupture. Eye, 2009 Jan 23. [Epub ahead of print]